Growth Hormone Secretagogues (GHS) (28 Offers)
Laboratory Tested
Domestic & International
You will save $28.00
-40% OFF
Peptide Hubs
Product Information
Peptide HubsCompound Details
Active Formula
2 Actives
Tesamorelin
5 mg
Ipamorelin
5 mg
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Varies by Active (30 Min – 2 Hours)
Detection Limited data · Up to several weeks
Primary Mechanism GHRH + Ghrelin Receptor Agonism
GH / IGF-1 Impact High
$42.00
$70.00
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Ipamorelin Lyophilized growth hormone releasing peptide
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 2 Hours
Detection Up to several weeks
Primary Mechanism Ghrelin / GHS-R1a Receptor Agonism
GH / IGF-1 Impact Moderate to High
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Sermorelin Acetate Lyophilized GHRH analogue (GHRH 1-29)
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 10–20 Minutes
Detection Up to several weeks
Primary Mechanism GHRH Receptor Agonism
GH / IGF-1 Impact Moderate
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Tesamorelin Lyophilized GHRH analogue (GHRH 1-44)
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 30–40 Minutes
Detection Up to several weeks
Primary Mechanism GHRH Receptor Agonism
GH / IGF-1 Impact Moderate to High
Kalpa Pharmaceuticals LTD, India
Product Information
Kalpa PharmaceuticalsCompound Details
Active Substance Ipamorelin Lyophilized growth hormone releasing peptide
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 2 Hours
Detection Up to several weeks
Primary Mechanism Ghrelin / GHS-R1a Receptor Agonism
GH / IGF-1 Impact Moderate to High
Kalpa Pharmaceuticals LTD, India
Product Information
Kalpa PharmaceuticalsCompound Details
Active Substance Sermorelin Acetate Lyophilized GHRH analogue (GHRH 1-29)
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 10–20 Minutes
Detection Up to several weeks
Primary Mechanism GHRH Receptor Agonism
GH / IGF-1 Impact Moderate
Kalpa Pharmaceuticals LTD, India
Product Information
Kalpa PharmaceuticalsCompound Details
Active Substance Tesamorelin Lyophilized GHRH analogue (GHRH 1-44)
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 30–40 Minutes
Detection Up to several weeks
Primary Mechanism GHRH Receptor Agonism
GH / IGF-1 Impact Moderate to High
Product Information
Peptide HubsCompound Details
Active Substance GHRP-6 Lyophilized growth hormone releasing peptide
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Multidose Vial
Estimated Half-Life Approximately 15–60 Minutes
Detection Limited data · Up to several weeks
Primary Mechanism Ghrelin / GHS-R1a Receptor Agonism
GH / IGF-1 Impact High
Peptide Hubs
Product Information
Peptide HubsCompound Details
Active Substance Tesamorelin Lyophilized GHRH analogue (GHRH 1-44)
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 30–40 Minutes
Detection Limited data · Up to several weeks
Primary Mechanism GHRH Receptor Agonism
GH / IGF-1 Impact Moderate to High
Axiolabs
Product Information
AxiolabsCompound Details
Active Substance Ipamorelin Lyophilized growth hormone releasing peptide
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 2 Hours
Detection Up to several weeks
Primary Mechanism Ghrelin / GHS-R1a Receptor Agonism
GH / IGF-1 Impact Moderate to High
Axiolabs
Product Information
AxiolabsCompound Details
Active Substance Sermorelin Acetate Lyophilized GHRH analogue (GHRH 1-29)
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 10–20 Minutes
Detection Up to several weeks
Primary Mechanism GHRH Receptor Agonism
GH / IGF-1 Impact Moderate
Axiolabs
Product Information
AxiolabsCompound Details
Active Substance Tesamorelin Lyophilized GHRH analogue (GHRH 1-44)
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 30–40 Minutes
Detection Up to several weeks
Primary Mechanism GHRH Receptor Agonism
GH / IGF-1 Impact Moderate to High
